Insider trade

Officer sold ~$399K of ALNY shares in the open market

Traded Oct 2, 2026 · Filed Oct 7, 2026

~$399K
Approx. value · 1,758 sh @ $226.88: 13K
Holds after · shares reported: +1.9%
Since filing · from the first close after the filing, $219.72 → $223.94 on Oct 6, S&P 500 +1.2%

Why it stands out

Alnylam Pharmaceuticals's CLO and Secretary sold $399K of Alnylam Pharmaceuticals shares. The filing references tax withholding.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$398,855

Shares × reported transaction price

Timing vs results

64 days after results of Jul 30, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references tax withholding

Only flagged when a footnote says so; never inferred

Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units.

Planned, from payFiled 5d ago